The good news is that treatment options for lung cancer patients are rapidly improving. In the last two years, more treatments have been approved by the United States Food and Drug Administration (FDA) for the treatment of lung cancer than had been approved in the prior ten years. New and life saving treatments, along with clinical trials, are happening rapidly and LCFA is committed to keeping you up to date on the latest, most hopeful and helpful, information.
From Fierce Pharma Looking to find their niche in the ultra-lucrative non-small cell lung cancer market, some immuno-oncology companies have turned to investigational biomarker TMB, or tumor mutational burden, in hopes of ID’ing patie…
Potentially First Approved KRAS Treatment From Reuters: An experimental Amgen Inc drug that targets a specific genetic mutation reduced tumor size in around half of advanced lung cancer patients given the highest dose in a small, ear…
From Drugs.com: FDA Approves Entrectinib for People With ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors Entrectinib approval Genentech, a member of the Roche Group, today announced…
From: IASLC Lung Cancer News Although the discovery of liquid biopsy testing looks to be a promising, non-invasive test to determine a patient's biomarkers, it hasn't been adopted into the mainstream quite yet. Targeted therapy has …
From Targeted Oncology Sequential afatinib (Gilotrif) followed by osimertinib (Tagrisso) has demonstrated a long-term overall survival (OS) of close to 4 years in patients with non–small cell lung cancer (NSCLC) who have EGFR&nbs…
From Massachusetts General Hospital Blood test to ID lung cancer By examining both blood samples and tumor tissues from patients with non-small-cell lung cancer (NSCLC), investigators at Massachusetts General Hospital (MGH) have iden…
From The New York Times Fewer than 5 percent of cancer patients participate in research that could improve care. Clinical Trial Navigators could help patients find the right studies. Since a Phase I trial has prolonged my life for al…
FDA approves Keytruda The FDA approved pembrolizumab monotherapy for patients with metastatic small cell lung cancer that progressed on or after platinum-based chemotherapy and at least one other prior line of therapy. This marks…
From Science Direct Relationship between air pollution and lung cancer in nonsmokers - is there one? For never-smokers (smoked <100 lifetime cigarettes), lung cancer has emerged as an important issue. We aimed to investigate the …
From MedScape 'How Could We Fail so Miserably?' Real-World Evidence Offers Sobering Reality We are doing an unconscionably poor job of delivering appropriate targeted therapies to our patients. That's the only conclusion I can draw, bas…